1. |
胡大一, 孙艺红. 心房颤动的流行病学和治疗现状. 中华全科医师杂志, 2006, 5(1): 5-7.
|
2. |
Di Biase L, Mohanty P, Mohanty S, et al. Ablation vs. amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC multicenter randomized trial. Circulation, 2016, 133(17): 1637-44.
|
3. |
Vítovec J, Špinar J, Špinarová L. Arrhythmias and conductance disturbances and heart failure. VnitrLek, 2018, 64(9): 874-877.
|
4. |
Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol, 2004, 43(6): 1004-1009.
|
5. |
Nedios S, Sommer P, Dagres N, et al. Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: The importance of rhythm and rate control. Heart Rhythm, 2014, 11(3): 344-351.
|
6. |
Khan MN, Jaïs P, Cummings J, et al. PABA-CHF investigators: pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med, 2008, 359(17): 1778-1785.
|
7. |
马南, 姜兆磊, 陈飞, 等. 梅氏微创消融术治疗心房颤动 207 例. 中国胸心血管外科临床杂志, 2015, 22(11): 996-999.
|
8. |
Mei J, Ma N, Ding F, et al. Complete thoracoscopic ablation of the left atrium via the left chest for treatment of lone atrial fibrillation. J Thorac Cardiovasc Surg, 2014, 147(1): 242-246.
|
9. |
马南, 梅举, 卢荣鑫, 等. 梅式微创消融术治疗导管消融失败心房颤动者的临床结果. 中华心血管病杂志, 2018, 46(8): 601-605.
|
10. |
李建美, 郑甲林, 陶四明, 等. 导管消融持续性房颤合并心力衰竭患者的治疗进展. 医学综述, 2011, 17(24): 3750-3753.
|
11. |
Anselmino M, Grossi S, Scaglione M, et al. Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function. J Cardiovasc Electrophysiol, 2013, 24(1): 24-32.
|
12. |
Rillig A, Makimoto H, Wegner J, et al. Six-year clinical outcomes after catheter ablation of atrial fibrillation in patients with impaired left ventricular function. J Cardiovasc Electrophysiol, 2015, 26(11): 1169-1179.
|
13. |
Jarman JWE, Hussain W, Wong T, et al. Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment. BMC Cardiovasc Disord, 2018, 18(1): 211.
|
14. |
Pappone C, Radinovic A, Manguso F, et al. Atrial fibrillation progression and management: a 5-year prospective follow-up study. Heart Rhythm, 2008, 5(11): 1501-1507.
|
15. |
Schreiber D, Rostock T, Fröhlich M, et al. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success. Circ Arrhythm Electrophysiol, 2015, 8(2): 308-317.
|
16. |
Ma N, Zhao D, Zhao N, et al. Study on left atrial dimension and function after modified endoscopic procedure for atrial fibrillation at two years' follow-up. Ann Thorac Surg, 2016, 101(5): 1724-1728.
|
17. |
Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol, 2013, 61(18): 1894-1903.
|
18. |
Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol, 2014, 7(1): 31-38.
|
19. |
Santangeli P, Marchlinski FE. Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. Heart Rhythm, 2017, S1547-5271(17): 30289-30298.
|
20. |
Zembala M, Filipiak K, Kowalski O, et al. Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus rhythm in long-term observation. Arch Med Sci, 2017, 13(1): 109-117.
|